Back
Mercury General Vs. Avidity Biosciences Industry Stock Comparison
Buy
56
MCY
Mercury General
Last Price:
$57.25
Seasonality Move:
5.13%
Sell
32
RNA
Avidity Biosciences
Last Price:
$31.10
Seasonality Move:
-10.33%
Buy
56
Mercury General (MCY)
is a Buy
Is Mercury General a Buy, Sell or Hold?
-
The current Mercury General [MCY] share price is $57.25. The Score for MCY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
MCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $31.11. The Score for RNA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MCY Stock Price Chart
What is Mercury General's stock price today?
-
The Mercury General share price today is $57.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MCY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $31.11The current trend is relatively stagnant and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
MCY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 62.78 | Buy |
Chaikin Money Flow: | 491926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.55 - 55.37) | Buy |
Bollinger Bands (100): | (52.87 - 73.03) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 50.29 | Buy |
Chaikin Money Flow: | -1147153 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.65 - 33.51) | Sell |
Bollinger Bands (100): | (29.36 - 43.08) | Sell |
MCY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.72 | Buy |
20-day SMA: | 54.21 | Buy |
50-day SMA: | 54.09 | Buy |
200-day SMA: | 60.7 | Sell |
8-day EMA: | 55.04 | Buy |
20-day EMA: | 54.19 | Buy |
50-day EMA: | 55.96 | Buy |
200-day EMA: | 58.11 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.52 | Buy |
20-day SMA: | 30.84 | Buy |
50-day SMA: | 30.96 | Buy |
200-day SMA: | 38.59 | Sell |
8-day EMA: | 30.94 | Buy |
20-day EMA: | 30.97 | Buy |
50-day EMA: | 32.16 | Sell |
200-day EMA: | 34 | Sell |
Mercury General Earnings Growth & MCY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.55 per share, and an increase next year of $5.75 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.57 per share.
Mercury General Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |